UNKNOWN

FEED

The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company''s growth as a commercial-stage oncology organization.

YEAR

Revolution Medicines Inc

Associate Director, Compliance, Field Commercialization West

Partner cross-functionally with Medical Affairs, Clinical Development, Translational Medicine, Research, Medical Communications, HEOR, Market Access, Commercial, and Field Medical teams to align external engagement strategies with enterprise priorities. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.

Revolution Medicines

Director, External Scientific Society Engagement

Description: The Associate Director, Category Management -Commercial Data & Analytics will serve as the primary strategic leader and stakeholder manager within AbbVie's Commercial Procurement team, overseeing the global Market Research, Data & Analytics category. Build comprehensive long-range category strategies for sourcing and managing data sets such as sales data, physician and prescriber data, patient-level claims data, promotional response data, and market analytics.

AbbVie Inc

Associate Director Category Management - Commercial Data and Analytics

The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Partner cross-functionally with Medical Affairs, Clinical Development, Translational Medicine, Research, Medical Communications, HEOR, Market Access, Commercial, and Field Medical teams to align external engagement strategies with enterprise priorities.

The Director collaborates across Market Access, Medical Affairs, Compliance, Marketing, HUB vendors, specialty pharmacies, and healthcare providers to remove access barriers, enhance patient experience, and drive brand success. Insurance & Reimbursement Mastery: Advanced knowledge of benefit verification, prior authorizations, appeals, exclusions, out-of-network navigation, and medical necessity reviews; strong understanding of buy-and-bill/physician-administered therapies and coding (CPT/HCPCS, incl.

Glaukos Corp

Patient Access Liaison Director

AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. The successful candidate will integrate clinical demand with CMC and manufacturing plans, manage multiple concurrent global programs, and build scalable supply chain capabilities to support late-stage development and future commercialization.

Avalyn Pharma

Senior Director, Head of Supply Chain

This role is part of a global cross-functional team and interacts with Global Clinical Development, Clinical Management, Regulatory Affairs, Biostatistics, Value Evidence, Global Medical Affairs, Pharmacovigilance, Patient Advocacy & Stakeholder Management functions to ensure clinical development programs reflect appropriate patient-centric endpoint strategy and value differentiation needs in alignment with the target product profile across the product lifecycle. Minimum $169,222.00 - Maximum $253,000.00, plus incentive opportunity: The range shown represents a typical pay range or starting pay for individuals who are hired in the role to perform in the United States.

Otsuka

Associate Director, Clinical Outcome Assessment

Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options. Participate in the writing of final study reports and lead the data dissemination plan for projects under their care; including development of publications, abstracts, and presentations; represent the company at scientific meetings.

BioMarin Pharmaceutical

Senior Medical Director, Clinical Science

Cross-Functional Collaboration: Work closely with Preclinical, Biostatistics, Data Management, Clinical Supplies, Safety/PV, and Medical Affairs teams to ensure seamless study execution and IMP accountability, including sample management and study plan reviews. The company's platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs.

Structure Therapeutics Inc

Associate Director, Clinical Operations (SF Bay Area)

ea_via_bold

Zenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases.

Zenas BioPharma

Senior Director, Biomarker Development, Strategy And Operations

FULL_TIME

The Company's lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). Safety data review for quality, completeness, and consistency across clinical studiesMonitor PV performance metrics, key quality indicators, quality trends, and compliance metricsIdentify, investigate, and escalate actual or potential PV compliance issues.

Altimmune

Director, Pharmacovigilance Operations

Talent Acquisition

In this leadership position within Global Medical Affairs, the individual will establish and drive the overarching scientific communication strategy, publication planning, and medical information infrastructure supporting the immunology pipeline, including lead programs such as obexelimab and orelabrutinib across indications including IgG4-Related Disease (IgG4-RD), Systemic Lupus Erythematosus (SLE), and Multiple Sclerosis (MS). Zenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody.

Executive Director, Global Publications, Scientific Communications, And Medical Information

OTHER

The Director collaborates across Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Biostatistics, Data Management, Quality, and external partners to support proactive safety oversight and informed program decision-making. Cross-Functional Leadership & Safety Governance Partner with Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Biostatistics, Data Management, Quality, and external vendors to integrate safety considerations into study conduct and program strategy.

Dyne Therapeutics

Director, Drug Safety & Pharmacovigilance Scientist

greenhouse_via_bold

This role serves as the medical monitor on their assigned study(s), partnering closely with Clinical Development leadership, Clinical Operations, Pharmacovigilance, Regulatory Affairs, Biostatistics, Data Management, Translational Medicine, and other key stakeholders to support study design, protocol execution, medical review, data analysis, and regulatory deliverables. This role is responsible for ensuring participant safety, supporting high-quality study execution, interpreting emerging clinical and safety data, and providing timely medical input to study teams, investigators, vendors, and cross-functional partners.

Medical Director, Clinical Development

This is a highly visible, strategic safety leadership role that partners closely with R&D, Regulatory, Medical, Quality, and Commercial teams to support both innovation and lifecycle management across Haleon's portfolio of trusted consumer health brands. As an Associate Director, Consumer Safety Science, you will play a key role in shaping the safety strategy for some of the world's most trusted consumer health brands, helping ensure that consumers can confidently use our products every day.

Haleon Plc.

Associate Director, Consumer Safety Science

This position provides pharmacovigilance expertise to and lead collaborations with external partners as well as with other functions across Replimune, including Regulatory Affairs, Clinical Development, Clinical Operations, Medical Affairs, or the Commercial to ensure that drug safety communications are accurate, complete and consistent. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response.

Replimune Group, Inc.

Senior Medical Director, Global Drug Safety

Lead and/or provide oversight for investigation and management of significant Clinical Study Quality Events: Identify, communicate, and escalate significant incidents of GCP non-compliance, quality risks, and inspection-readiness concerns, and drive timely resolution, ensuring appropriate executive visibility, escalation, and risk-based decision-making. Partner with CMC Quality, Clinical Operations, and senior cross-functional stakeholders to facilitate the investigation, escalation, and resolution of clinical supply quality issues such as temperature excursions, product complaints, and deviations reported from clinical sites, ensuring appropriate risk assessment, stakeholder communication, and CAPA linkage when applicable.

4D Molecular Therapeutics Inc

Senior Director, Clinical Quality Assurance CQA

Provide accurate, balanced, evidence-based, and timely responses to unsolicited medical and scientific inquiries from healthcare professionals, patients or caregivers, and internal colleagues, using approved response documents, current literature, and appropriate data on file. A key focus of the role will be supporting Medical Information readiness for the upcoming multiple myeloma launch, including development of scientific response resources, management of anticipated inquiry topics, and preparation of internal and external support teams.

WE THE TEKWISSEN PEOPLE TekWissen offers you a broader portfolio of services, industry-leading solutions, and the meaningful innovations that give you greater flexibility and speed to respond to market dynamics, reduced costs and risk to improve enterprise performance, and increased productivity to enable growth.To keep pace with global market demands, TekWissen keeps its finger on the pulse of change. Our organized approach to guiding a project from its inception to closure. Managing projects is becoming more and more important as we enter the digital era. To cope with the pace that this transition demands, a method is required to manage projects so they can yield quality work, while incorporating efficient use of time and resources. Project involves identifying which quality standards are relevant to the project and determining how to satisfy them. It is important to perform quality planning during the Planning Process and should be done alongside the other project planning processes because changes in the quality will likely require changes in the other planning processes, or the desired product quality may require a detailed risk analysis of an identified problem. It is important to remember that quality should be planned, designed, then built in, not added on after the fact. Capabilities and accomplishments in one TekWissen business enhance the opportunity for success in the others. Put simply, TekWissen's unique combination of attributes promotes success.

TekWissen LLC

Associate Director, Medical Information

Ceipal

Advise senior leaders and cross-functional teams on pharmaceutical promotion, HCP and patient interactions, patient-support programs, Medical Affairs independence, medical information, market access, pricing, government price reporting, and other commercialization risks. The role leads the development and oversight of a risk-based compliance framework for commercialization, advises senior leaders, and provides independent challenge on higher-risk business decisions.

SPARTAN TOOL, LLC Jobs in the United States

Associate Director, Compliance, Field Commercialization West Revolution Medicines Inc

Director, External Scientific Society Engagement Revolution Medicines

Associate Director Category Management - Commercial Data and Analytics AbbVie Inc

Director, External Scientific Society Engagement Revolution Medicines Inc

Patient Access Liaison Director Glaukos Corp

Senior Director, Head of Supply Chain Avalyn Pharma

Associate Director, Clinical Outcome Assessment Otsuka

Senior Medical Director, Clinical Science BioMarin Pharmaceutical

Associate Director, Clinical Operations (SF Bay Area) Structure Therapeutics Inc

Senior Director, Biomarker Development, Strategy And Operations Zenas BioPharma

Director, Pharmacovigilance Operations Altimmune

Executive Director, Global Publications, Scientific Communications, And Medical Information Zenas BioPharma

Director, Drug Safety & Pharmacovigilance Scientist Dyne Therapeutics

Medical Director, Clinical Development Dyne Therapeutics

Associate Director, Consumer Safety Science Haleon Plc.

Senior Medical Director, Global Drug Safety Replimune Group, Inc.

Senior Director, Clinical Quality Assurance CQA 4D Molecular Therapeutics Inc

Associate Director, Medical Information TekWissen LLC

Director Commercial Compliance Cencora Inc

Stand out to leading employers.